Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
- First Posted Date
- 2012-04-09
- Last Posted Date
- 2016-03-25
- Lead Sponsor
- Akinion Pharmaceuticals AB
- Target Recruit Count
- 25
- Registration Number
- NCT01573247
- Locations
- 🇨🇿
University Hospital Kralovske Vinohrady, Prague, Czech Republic
🇵🇱MTZ Clinical Research Inc., Warsaw, Poland
🇸🇪Sahlgrenska University Hospital, Gothenburg, Sweden
© Copyright 2025. All Rights Reserved by MedPath